MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

5 Medical Technologies to Watch in 2015: Next-Generation Sequencing

Next-Generation Sequencing Illumina’s HiSeq X Ten cracked the $1000 genome, opening the floodgates for other next-generation sequencing technologies.

Three companies—Illumina; LifeTechnologies, which Thermo Fisher Scientific acquired this year; and Roche—have thus far owned the gene sequencing market. But competition is heating up.

Over the past year, the number of firms competing in the space rose by almost 10, nearly tripling the field, according to Frost & Sullivan. Mergers and acquisitions also mixed things up in 2014.

“In order to gain access to newer technologies, companies like Bio Rad and Roche acquired companies such as Genia and Gnubio, who had promising technology platforms based on nanopore sequencing,” says Divyaa Ravishankar, a senior life sciences industry analyst with Frost & Sullivan. 

          

TAGS: News
Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish